Compound Detail
CHEMBL1601669
ALFACALCIDOL 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
Basic Information
| ChEMBL ID | CHEMBL1601669 |
| Name | ALFACALCIDOL |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | OFHCOWSQAMBJIW-AVJTYSNKSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL846 |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
20
Publications
23
Known Names
8
Indications
1
Mechanisms
Molecular Properties
400.6
MW (Da)
6.59
ALogP
2
HBA
2
HBD
40.5
PSA (Ų)
0.53
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vitamin D receptor agonist | AGONIST | Vitamin D3 receptor | ✓ | ✓ |
Indications
Muscular Diseases Osteoporosis Osteoporosis, Postmenopausal Pelvic Organ Prolapse Calcinosis Death, Sudden, Cardiac Renal Insufficiency Scoliosis
ATC Classification
A11CC03
alfacalcidol
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: VITAMINS
Activity Summary
IC50 1 meas. best 6.0
Ki 1 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 6.0 | 6.0 | 1009.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Sodium-dependent noradrenaline transporter | IC50 | = | 1009.0 | nM | 6.0 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-5... | - |
| Sodium-dependent noradrenaline transporter | Ki | = | 1000.0 | nM | 6.0 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-5... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 202 |
| 25874339 | 10.1016/j.ejmech.2015.04.016 | Rattus norvegicus | 14 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| - | 10.1016/S0960-894X(96)00245-4 | Unchecked | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 1 |
Data from ChEMBL 36 via Core Engine